Summary
President Donald Trump plans to announce a deal with AstraZeneca to reduce prescription drug prices in the U.S. This agreement introduces a "most-favored-nation" pricing model aimed at making medications more affordable, especially for low-income Americans.
Key Facts
- President Trump will announce a deal with AstraZeneca to lower drug prices.
- The pricing model ties U.S. drug prices to the lowest prices in other developed countries.
- The plan aims to make medications more affordable for low-income people, including those on Medicaid.
- A new platform called TrumpRx will provide discounted prescription prices.
- AstraZeneca CEO Pascal Soriot will join President Trump for the announcement.
- "Most-favored-nation" pricing means using the cheapest international rates.
- The deal's details are not yet officially confirmed by the White House or AstraZeneca.
